Early indicators, early treatments, neuroprotection in multiple sclerosis /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Milano ; New York :
Springer,
[2004]
|
| Series: | Topics in neuroscience.
|
| Subjects: |
Table of Contents:
- Evidence for an early treatment of multiple sclerosis
- Inflammation, demyelination, and axonal degeneration : three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
- Genetic regulation of nerve cell death/glial activation and protective effects of myelin basic protein autoimmune neurotrophin production in mechanically induced neurodegeneration
- Neuroprotective treatment in primary progressive multiple sclerosis : a phase I/II study with riluzole
- Neuropathology and disease progression in multiple sclerosis
- Autoimmune inflammation and multiple sclerosis
- Early treatment of progression in multiple sclerosis
- Imaging for tissue characterization in multiple sclerosis and other white matter diseases
- Monounsaturated fatty acids and neuroprotection : the results of a study of cognitive decline in old age : is there a case for this treatment in multiple sclerosis
- Neuroprotection in acute ischemic stroke : lessons for early treatment in multiple sclerosis
- Soluble VCAM-1 release indicates inflammatory blood-brain barrier pathology and further modulates adhesion
- Early treatment in multiple sclerosis with intravenous immunoglobulin : rationale and study design
- Serial magnetic resonance imaging in patients with a first clinial episode suggestive of multiple sclerosis : outline of a research protocol
- T1-hypointensive lesions (T1 black holes) in mild-to-moderate disability relapsing multiple sclerosis
- Acute monosymptomatic optic neuritis : potential clues to early therapy in multiple sclerosis
- Antibody mediated demyelination
- Anti-MOG antibodies as early predictors for conversion to relapsing-remitting disease course in patients suggestive of multiple sclerosis
- Sunlight, vitamin D, and multiple sclerosis
- The yin and yang of inflammation in multiple sclerosis
- Management of interferon-β1b (betaseron) failures in multiple sclerosis with interferon-αn3 (alferon N)